Search research articles
Contact Us
Filters
Showing results (21-30 of 94) with videos related to
Page
of 10
Sort By:
European Journal of Haematology
|
March 29, 2014
Salvage therapy with pegylated liposomal doxorubicin, bortezomib, cyclophosphamide, and dexamethasone in relapsed/refractory myeloma patients
Alessandra Romano, Annalisa Chiarenza, Concetta Conticello, et al.
Clinical Case Reports
|
September 20, 2019
A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones?
Uros Markovic, Valeria Calafiore, Enrica Martino, et al.
Acta Haematologica
|
April 17, 2023
Multicentric Castleman Disease and Concurrent Hematological Disorders: The Occurrence of Plasmacytoma and the Hypotheses Arising from Literature Review
Andrea Duminuco, Alessandra Romano, Elena Sabattini, et al.
World Journal of Gastrointestinal Endoscopy
|
August 13, 2015
Rare gastrointestinal lymphomas: The endoscopic investigation
Calogero Vetro, Giacomo Bonanno, Giorgio Giulietti, et al.
Oncotarget
|
March 2, 2016
Heme oxygenase-1 nuclear translocation regulates bortezomibinduced cytotoxicity and mediates genomic instability in myeloma cells
Daniele Tibullo, Ignazio Barbagallo, Cesarina Giallongo, et al.
Cancers
|
December 10, 2021
Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective Study
Uros Markovic, Alessandra Romano, Claudia Bellofiore, et al.
Hematological Oncology
|
December 23, 2011
Endoscopic ultrasonography in gastric lymphomas: appraisal on reliability in long-term follow-up
Calogero Vetro, Alessandra Romano, Annalisa Chiarenza, et al.
Hematological Oncology
|
May 6, 2011
Effects of second-generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donors
Daniele Tibullo, Ignazio Barbagallo, Cesarina Giallongo, et al.
Acta Haematologica
|
November 28, 2021
Belantamab Mafodotin and Relapsed/Refractory Multiple Myeloma: This Is Not Game Over
Annalisa Condorelli, Bruno Garibaldi, Caterina Gagliano, et al.
Clinical Case Reports
|
April 11, 2020
Serum free light chains and multiple myeloma: Is it time to extend their application?
Uros Markovic, Valerio Leotta, Daniele Tibullo, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 94) with videos related to
Sort By:
Page
of 10
European Journal of Haematology
|
March 29, 2014
Salvage therapy with pegylated liposomal doxorubicin, bortezomib, cyclophosphamide, and dexamethasone in relapsed/refractory myeloma patients
Alessandra Romano, Annalisa Chiarenza, Concetta Conticello, et al.
Clinical Case Reports
|
September 20, 2019
A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones?
Uros Markovic, Valeria Calafiore, Enrica Martino, et al.
Acta Haematologica
|
April 17, 2023
Multicentric Castleman Disease and Concurrent Hematological Disorders: The Occurrence of Plasmacytoma and the Hypotheses Arising from Literature Review
Andrea Duminuco, Alessandra Romano, Elena Sabattini, et al.
World Journal of Gastrointestinal Endoscopy
|
August 13, 2015
Rare gastrointestinal lymphomas: The endoscopic investigation
Calogero Vetro, Giacomo Bonanno, Giorgio Giulietti, et al.
Oncotarget
|
March 2, 2016
Heme oxygenase-1 nuclear translocation regulates bortezomibinduced cytotoxicity and mediates genomic instability in myeloma cells
Daniele Tibullo, Ignazio Barbagallo, Cesarina Giallongo, et al.
Cancers
|
December 10, 2021
Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective Study
Uros Markovic, Alessandra Romano, Claudia Bellofiore, et al.
Hematological Oncology
|
December 23, 2011
Endoscopic ultrasonography in gastric lymphomas: appraisal on reliability in long-term follow-up
Calogero Vetro, Alessandra Romano, Annalisa Chiarenza, et al.
Hematological Oncology
|
May 6, 2011
Effects of second-generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donors
Daniele Tibullo, Ignazio Barbagallo, Cesarina Giallongo, et al.
Acta Haematologica
|
November 28, 2021
Belantamab Mafodotin and Relapsed/Refractory Multiple Myeloma: This Is Not Game Over
Annalisa Condorelli, Bruno Garibaldi, Caterina Gagliano, et al.
Clinical Case Reports
|
April 11, 2020
Serum free light chains and multiple myeloma: Is it time to extend their application?
Uros Markovic, Valerio Leotta, Daniele Tibullo, et al.
Page
of 10